March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in you in box.
Are you ready to begin treatment? Get the basics about HIV, how to decide when to start, and approaching treatment with a positive attitude.
Learn about the physical, mental, social, and emotional changes that teens go through and how to support them as they grow into adults.